Estimation of the risk of type 2 diabetes mellitus in the adult population
DOI:
https://doi.org/10.70577/tvjh6k69Keywords:
Score, Risk; Diabetes Mellitus; Population.Abstract
Objective: type 2 diabetes mellitus represents a growing global public health problem due to its high morbidity and mortality rates and the presence of modifiable risk factors. Materials and methods: a quantitative, non-experimental, cross-sectional, and correlational study conducted among 105 adults in a captive population. The FINDRISC test was applied to classify the 10-year risk of T2DM. Statistical analysis was performed in Jamovi 2.6.44 using descriptive statistics and Pearson’s chi-square test, with a significance level of p < 0.05. Results: the low-risk (34.0%) and slightly elevated-risk (33.0%) categories predominated. However, 18.0% had moderate risk, 14.0% had high risk, and 6.0% had very high risk. The clinical profile showed frequent abnormalities in fasting blood glucose, blood pressure, and serum lipids. Although women accounted for a higher proportion in the high- and very high-risk categories, no significant association was found between sex and FINDRISC risk level (χ² = 3.21; p = 0.523). Conclusions: a significant proportion of adults are at clinically relevant risk of developing T2D, supporting the use of FINDRISC as a screening tool to guide comprehensive and timely preventive interventions).
Downloads
References
1. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan B, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Research and Clinical Practice. 2022; 183(1): p. 109119. DOI: https://doi.org/10.1016/j.diabres.2021.109119
2. World Health Organization. Diabetes. [Online].; 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes.
3. Global Burden of Disease Collaborative Network. Results. Institute for Health Metrics and Evaluation. [Online].; 2024. Available from: https://vizhub.healthdata.org/gbd-results/.
4. Ture N, Emecen A, Unal B. Validation of the Finnish Diabetes Risk Score and development of a country-specific diabetes prediction model for Turkey. Primary Health Care Research & Development. 2025; 26(1): p. e18. DOI: https://doi.org/10.1017/S1463423625000180
5. Gabriel R, Acosta T, Florez K, Lindstrom J, Tuomilehto J, Aschner P. Validation of the Finnish Type 2 Diabetes Risk Score (FINDRISC) with the OGTT in Health Care Practices in Europe. Diabetes Research and Clinical Practice. 2021; 178: p. 108976. DOI: https://doi.org/10.1016/j.diabres.2021.108976
6. Bagyura Z, Loretta Z, Kiss I. Validation of the Finnish Diabetes Risk Score (FINDRISC) in a Central-European Population for the Prediction of Cumulative Incidence of Type 2 Diabetes Over 8-Years—Follow-Up of the Budakalász Health Examination Survey (BHES). Diabetes/Metabolism Research and Reviews. 2025; 41(8): p. e70105. DOI: https://doi.org/10.1002/dmrr.70105
7. Abdallah M, Sharbaji S, Sharbaji M, Daher Z, Faour T, Mansour Z, et al. Diagnostic accuracy of the Finnish Diabetes Risk Score for the prediction of undiagnosed type 2 diabetes, prediabetes, and metabolic syndrome in the Lebanese University. Diabetol Metab Syndr. 2020; 12(84): p. 2-11. DOI: https://doi.org/10.1186/s13098-020-00590-8
8. Mugume I, Wafula S, Kadengye D, Van Olmen J. Performance of a Finnish Diabetes Risk Score in detecting undiagnosed Diabetes Risk Score in detecting undiagnosed. PLoS ONE. 2023; 18(4): p. e0276858. DOI: https://doi.org/10.1371/journal.pone.0276858
9. Jin S, Chen Q, Han X, Liu Y, Cai M, Yao Z, et al. Comparison of the Finnish Diabetes Risk Score Model With the Metabolic Syndrome in a Shanghai Population. Front. Endocrinol. 2022; 13(725314): p. 1-11. DOI: https://doi.org/10.3389/fendo.2022.725314
10. Pertiwi P, Perwitasari D, Satibi S. Validation of Finnish Diabetes Risk Score Indonesia Version in Yogyakarta. Borneo Journal of Pharmacy. 2021; 4(1): p. 57-67. DOI: https://doi.org/10.33084/bjop.v4i1.1575
11. Nieto-Martinez R, Barengo N, Restrepo M, Grinspan A, Assefi A, Mechanick J. Large scale application of the Finnish diabetes risk score in Latin American and Caribbean populations: a descriptive study. Front Endocrinol (Lausanne). 2023; 15(1188784). DOI: https://doi.org/10.3389/fendo.2023.1188784
12. Pesaro A, Bittencourt M, Franken M, Carvalho J, Bernardes D, Tuomilehto J, et al. The Finnish Diabetes Risk Score (FINDRISC), incident diabetes and low-grade inflammation. Diabetes Research and Clinical Practice. 2021; 171(108558). DOI: https://doi.org/10.1016/j.diabres.2020.108558
13. Alcivar J, Cardenas K, Rodríguez L. Evaluación del riesgo de diabetes mellitus tipo 2 mediante el test FINDRISK en personal de la Universidad Laica Eloy Alfaro de Manabí. Recimundo. 2025; 9(2): p. 863-882. DOI: https://doi.org/10.26820/recimundo/9.(2).abril.2025.863-882
14. Montero C, Mauna S, Clavijo C, Charry J, Guerrero F. Riesgo para desarrollar diabetes tipo 2 mediante aplicación del test FINDRISC y factores asociados en población adulta del cantón Pucará-Azuay. 2023. RECIAMUC. 2023; 7(2): p. 779-794. DOI: https://doi.org/10.26820/reciamuc/7.(2).abril.2023.779-794
15. Bell V, Rodrigues A, Costa V, Dias C, Alpalhão M, Martins I, et al. Assessing Type 2 Diabetes Risk in the Post-Pandemic Era: A Pharmacy-Led FINDRISC Screening Study. Life. 2024; 14(12): p. 1558. DOI: https://doi.org/10.3390/life14121558
16. Yovera-Aldana M, Mezones-Holguin E, Aguero-Zamora R, Damas-Casani L, Uriol-Llanos B, Espinoza-Morales F, et al. External validation of Finnish diabetes risk score (FINDRISC) and Latin American FINDRISC for screening of undiagnosed dysglycemia: Analysis in a Peruvian hospital health care workers sample. PLoS ONE. 2024; 19(8): p. e0299674. DOI: https://doi.org/10.1371/journal.pone.0299674
17. Reyes M, Santos M. Evaluación del riesgo de desarrollar Diabetes Mellitus tipo 2 mediante el test FINDRISC. Revista Científica Internacional. 2025;: p. 1-14. DOI: https://doi.org/10.36314/cunori.v9i1.338
18. Varela-Vega Y, Roy-García I, Pérez-Rodríguez M, Velázquez-López L. Diagnostic performance of the FINDRISC questionnaire to identify insulin resistance in adults. Rev Med Inst Mex Seguro Soc. 2023; 61(1): p. 33-41.
19. Ademola A, Innocente O, Bello F, Belarabe H, Bafeshi M. Knowledge and risk assessment of diabetes mellitus at a tertiary institution in Zaria and the impact of a 1-h World Diabetes Day public lecture on knowledge. African Journal of Endocrinology and Metabolism. 2024; 14(1): p. 93-100.
20. Arnardóttir E, Sigurðardóttir Á, Graue M, Beate-Christin H, Skinner T. Using HbA1c measurements and the Finnish Diabetes Risk Score to identify undiagnosed individuals and those at risk of diabetes in primary care. BMC Public Health. 2023; 23(211). DOI: https://doi.org/10.1186/s12889-023-15122-y
21. Hamedi A, Seif M, Hossein M, Rezaianzadeh A, Hassanzadeh J. Performance of the finnish diabetes risk score in screening for undiagnosed type 2 diabetes among adults without prior diagnosis: A Kharameh Cohort Study, Iran. Primary Care Diabetes. 2025; 19(5): p. 517-521. DOI: https://doi.org/10.1016/j.pcd.2025.07.001
22. Zulema M, Viniegra M, Gagliardino J, Lucarelli C, Maccallini G, Frusti M. Relación entre el Finnish Diabetes Risk Score, glucemia en ayunas y hemoglobina A1c. Revista de la Sociedad Argentina de Diabetes. 2023; 57(2): p. 75-83. DOI: https://doi.org/10.47196/diab.v57i2.624
23. Salinero-Fort M, Mostaza-Prieto J, Lahoz-Rallo C. External validation of three diabetes prediction scores in a Spanish cohort: does adding high risk for depression improve the validation of the FINDRISC score (FINDRISC-MOOD)? BMJ Open. 2024; 14: p. e083121. DOI: https://doi.org/10.1136/bmjopen-2023-083121
24. Peralta H, Costa J, Saleme A. EVALUACIÓN DEL PUNTAJE FINDRISC PARA DETECCIÓN DE PREDIABETES Y DIABETES TIPO 2 SIN DIAGNÓSTICO. Medicina. 2024; 81: p. 1-10.
25. Acosta-Reyes J, Rodríguez D, Acosta T, Aschner P, Fraga C, Vazquez-Fernandez A, et al. Finnish diabetes risk score (findrisc) for type 2 diabetes screening compared with the oral glucose tolerance test: A systematic review and meta-analysis of diagnostic test accuracy. Diabetes Research and Clinical Practice. 2025; 229. DOI: https://doi.org/10.1016/j.diabres.2025.112480
26. Nölken K, Linseisen J, Raake P. Diabetes mellitus risk in post-myocardial infarction patients: FINDRISC versus self-assessment—a cross sectional study. Cardiovasc Diabetol. 2025; 24(1): p. 23. DOI: https://doi.org/10.1186/s12933-024-02551-1
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Dayana Yuleise Henriquez Rivas, Liseth Estefanía Gaona Luna, Sandra Verónica Falconí Peláez, José Manuel Reyes Romero (Autor/a)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
